Valuation: Guided Therapeutics, Inc.

Market Cap 23.17M 20.31M 18.73M 17.53M 32.87M 2.19B 33.56M 225M 87.09M 1.08B 87M 85.1M 3.75B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 26.04M 22.84M 21.05M 19.71M 36.95M 2.46B 37.72M 253M 97.9M 1.21B 97.8M 95.66M 4.21B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day-7.69%
1 week-17.24%
Current month+4.80%
1 month+4.80%
3 months+20.30%
6 months-33.33%
Current year-55.56%
1 week 0.22
Extreme 0.22
0.26
1 month 0.18
Extreme 0.1805
0.34
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
9,280
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 70 2016-11-30
Director/Board Member 76 2006-04-09
Chairman 67 2013-09-30
Date Insider Type Main position Quantity % Market Cap.
Mar. 09Others

Director

10 0.9747%
Mar. 09Free

Chairman

110,000 0.1316%
Mar. 09Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-7.69%-17.24%-14.29%-5.99% 23.17M
+1.44%+10.42%+25.66%+0.67% 191B
+1.25%-0.51%-24.17%+22.63% 143B
+1.75%+10.74%-1.31%-16.09% 139B
+0.07%-2.34%-58.48%-17.31% 65.74B
+1.18%+3.91%+16.07%+0.65% 52.27B
-0.52%-0.03%-27.04%-31.75% 43.55B
+0.37%+7.04%+14.13%+16.21% 38.41B
-0.66%+5.34%+6.24%+45.27% 36.76B
+1.26%+6.77%-11.59%-14.67% 29.91B
Average -0.16%+2.28%-7.48%-0.04% 73.95B
Weighted average by Cap. +1.04%+5.18%-3.40%+0.67%

Financials

2024 2025
Net sales 7K 6.14K 5.66K 5.3K 9.93K 660K 10.14K 68K 26.31K 326K 26.28K 25.71K 1.13M 767K 673K 620K 580K 1.09M 72.35M 1.11M 7.45M 2.88M 35.76M 2.88M 2.82M 124M
Net income -2.42M -2.12M -1.95M -1.83M -3.43M -228M -3.5M -23.48M -9.09M -113M -9.08M -8.88M -391M -3.2M -2.8M -2.58M -2.42M -4.53M -301M -4.63M -31.05M -12.01M -149M -12M -11.74M -517M
Net Debt 1.77M 1.55M 1.43M 1.34M 2.51M 167M 2.56M 17.2M 6.66M 82.57M 6.65M 6.5M 286M 2.88M 2.52M 2.32M 2.18M 4.08M 271M 4.17M 27.94M 10.81M 134M 10.8M 10.56M 465M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-06-26 $0.2400 -7.69% 106
26-06-25 $0.2600 0.00% 101
26-06-23 $0.2600 -1.89% 14,600
26-06-22 $0.2650 -8.62% 250
  1. Stock Market
  2. Stocks
  3. GTHP Stock